Skip to main content
Elsevier

Journals in Clinical trials

Supporting researchers, clinicians, and regulatory professionals, this portfolio emphasizes trial design, ethical considerations, and statistical analysis. It features innovations in trial methodology, real-world evidence, and regulatory compliance that accelerate drug development and facilitate evidence-based healthcare advancements.

  • Contemporary Clinical Trials

    • ISSN: 1551-7144
    Contemporary Clinical Trials is an international peer reviewed journal that publishes manuscripts pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from disciplines including medicine, biostatistics, epidemiology, computer science, management science, behavioural science, pharmaceutical science, and bioethics. Full-length papers not exceeding 4,000 words, short communications not exceeding 1,500 words, as well as systemic reviews of clinical trials and methodologies will be published. Perspectives/comment... on current issues and the impact of clinical trials on the practice of medicine and health policy are also welcome.The following topics are covered in the journal:Unconvention... design features of specific trials and their rationalePreliminary or full results of clinical trials with unconventional design featuresStatistical methods for all aspects of clinical trialsMethodologies for clinical trial operations including trial management and optimization; patient recruitment and retention; and trial quality monitoring and assessmentData management methodologies including data collection; database maintenance; data quality assurance; safety monitoring and risk management; and patient registriesRegulatory requirements and their impact on clinical trialsEthical and legal considerations in clinical trialsRisk-benefit, cost-effectiveness and decision analyses in clinical trialsContemporary Clinical Trials is unique in that it is outside the confines of disease specifications, and it strives to adapt and grow with an expanding clinical trials landscape as the needs of clinical research evolve in today's dynamic healthcare environment.Having taken upon the important role as a platform for knowledge exchange between experts in different disciplines related to clinical trials, the ultimate goal of Contemporary Clinical Trials is to advance this field of research for the benefit of patients.Authors are also welcome to submit to the journal's open access companion title, Contemporary Clinical Trials Communications.
    Subscriptions

  • Clinical Therapeutics

    • ISSN: 0149-2918
    Clinical Therapeutics provides peer-reviewed, rapid publication of recent developments in drugs, biologicals, and other therapies as well as in diagnostics, pharmacoeconomics, health policy, treatment outcomes, and innovations in drug and biologics research and development. In addition, Clinical Therapeutics features updates on specific topics collated by expert Topic Editors and Guest Editors. Clinical Therapeutics is read by a large international audience of scientists and clinicians in a variety of research, academic, and clinical practice settings. Articles are indexed by all major biomedical abstracting databases.Published articles range from pivotal studies exploring new chemical entities in large, multicenter trials to those exploring repurposing of marketed agents. Additionally, pilot study reports that assess drug safety and tolerability in all phases of development, new routes of drug administration and formulations, pharmacokinetics, pharmacodynamics, bioavailability, and biosimilarity and changes in practice guidelines, standards, policies and regulations are all of interest for publication. Clinical Therapeutics also understands the importance of strengthening the body of publicly accessible evidence surrounding particular agents through the publication of replication studies, negative trials, and failed trials.Beyond therapeutic clinical applications, we seek reports that examine the real-world implications of therapeutics such as comparative effectiveness and pharmacoeconomics studies as well as work that has implications for health policy. Commentaries, which include perspectives and contemporary issues, are sought to offer a balance of viewpoints and scholarly opinion on a broad array of drug-related topics. Case reports, which remain a vital part of our mission, offer clinically valuable lessons. All manuscripts are peer reviewed by independent clinicians or scientists for clinical relevance, technical accuracy, methodological rigor, clarity, and objectivity using a blind review process.In addition to feature articles published monthly, Clinical Therapeutics regularly features a specific theme section dedicated to an annual update of a specific topic area. A special guest editor will comprise each update with reviews, commentaries, and original research highlighting what's new or controversial in the topical specialty. Authors are invited to submit manuscripts for consideration in the topic updates, identifying submissions as such in their cover letters. Submissions not selected for the updates will be considered for general publication. Submit your manuscript at https://www.editoria... manuscript types require prior editorial review before submission to ensure alignment with the journal’s scope and contribution to the field. Authors intending to submit the following types of studies should seek pre-submission approval by contacting the journal office at [email protected]... with a brief description of the proposed manuscript for editorial evaluation:Adverse event studies based on the FAERS database. Submissions must clearly articulate the novel contribution of the study and how it advances the existing literature. This justification should also be included in the cover letter.Drug–drug interaction studies. Manuscripts must provide a clear methodological rationale for the selection of the agents studied, including clinical or mechanistic justification described within the Methods section.Studies focused on alternative or complementary medicines, including traditional medical systems (e.g., Traditional Chinese Medicine) or supplementation-focu... interventions.Out-of... ContentClinical Therapeutics focuses on clinically relevant therapeutic research and studies with clear implications for patient care, therapeutic development, or health policy. The following manuscript categories are generally considered outside the scope of the journal and are not suitable for submission:Animal or preclinical studies without direct clinical applicationSimple innovator versus generic bioequivalence studies without broader clinical, pharmacological, or regulatory implicationsMendelia... randomization studiesMolecular docking or purely computational modeling studies without experimental or clinical validationHighly specialized discipline-specific studies (e.g., dermatology-, ophthalmology-, or imaging-focused research) that lack clear therapeutic relevance or broader clinical applicability
    Subscriptions

  • Advances in Medical Sciences

    • ISSN: 1896-1126
    Advances in Medical Sciences is an international, peer-reviewed journal that welcomes original research articles and reviews on current advances in life sciences, preclinical and clinical medicine, and related disciplines.The Journal’s primary aim is to make every effort to contribute to progress in medical sciences. The strive is to bridge laboratory and clinical settings with cutting edge research findings and new developments.Advance... in Medical Sciences publishes articles which bring novel insights into diagnostic and molecular imaging, offering essential prior knowledge for diagnosis and treatment indispensable in all areas of medical sciences. It also publishes articles on pathological sciences giving foundation knowledge on the overall study of human diseases. Through its publications Advances in Medical Sciences also stresses the importance of pharmaceutical sciences as a rapidly and ever expanding area of research on drug design, development, action and evaluation contributing significantly to a variety of scientific disciplines.The journal welcomes submissions from the following disciplines:General and internal medicine,Cancer research,Genetics,En... and Cardiovascular Medicine,Immunology and Allergy,Pathology and Forensic Medicine,Cell and molecular Biology,Haematology,... and Experimental Pathology.Only review articles from experts in the field will be considered for publication. The journal does not accept case reports.
    Subscriptions